MAP4K3 and non-small cell lung carcinoma: In addition, using the Kaplan-Meier survival analysis, NSCLC patients with GLK overexpression showed poor recurrence-free survival in females (n = 23, GLK-High versus GLK-Low, P = 0.020) but not in males (n = 35, GLK-High versus GLK-Low, P = 0.143).